Key facts
- This page summarizes Jacob D. Cohen's Form 4 filing for MANGOCEUTICALS, INC. (MGRX).
- 6 reported transactions and 6 derivative rows are listed below.
- Accepted by SEC: 20 Mar 2026, 17:00.
Jacob D. Cohen - 16 Mar 2026 Form 4 Insider Report for MANGOCEUTICALS, INC. (MGRX)
- Reporting relationship
- Chief Executive Officer, Director, 10%+ Owner
- Issuer ticker
- MGRX
- Reported as of
- 16 Mar 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 20 Mar 2026, 17:00:28 UTC
- Prior SEC filing
- 20 Mar 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jacob D. Cohen
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Jacob D. Cohen filed Form 4 for MANGOCEUTICALS, INC. (MGRX) on 20 Mar 2026.
Change
- Previous filing in this sequence was filed on 20 Mar 2026.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (2)
CIK 0001432078
Primary reporting owner
Cohen Jacob D.
- Relationship
- Chief Executive Officer, Director, 10%+ Owner
- Address
- C/O MANGOCEUTICALS, INC., 17130 N. DALLAS PARKWAY, SUITE 240, DALLAS
- Signature
- /s/ Jacob D. Cohen
- Signature date
- 20 Mar 2026
CIK 0001974475
Tiger Cub Trust
- Relationship
- 10%+ Owner
- Address
- C/O MANGOCEUTICALS, INC., 17130 N. DALLAS PARKWAY, SUITE 240, DALLAS
- Signature
- /s/ Jacob D. Cohen, Trustee, The Tiger Cub Trust
- Signature date
- 20 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
MGRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 200,000
- Date
- 16 Mar 2026
- Ownership
- Direct
- Footnotes
- F1
MGRX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 605,000
- Date
- 16 Mar 2026
- Ownership
- Direct
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
MGRX
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -50,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $16.50
- Footnotes
- F1, F3, F4
MGRX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +50,000
- Change %
- Price
- $0.000000*
- Shares after
- 50,000
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 50,000
- Exercise price
- $0.4500
- Footnotes
- F1, F3, F4
MGRX
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -83,333
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 83,333
- Exercise price
- $4.80
- Footnotes
- F1, F3
MGRX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +83,333
- Change %
- Price
- $0.000000*
- Shares after
- 83,333
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 83,333
- Exercise price
- $0.4500
- Footnotes
- F1, F3
MGRX
transaction
Derivative
Stock Option (right to buy)
Disposed to Issuer
- Transaction value
- Shares
- -2,000,000
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,000,000
- Exercise price
- $2.30
- Footnotes
- F1, F3, F5
MGRX
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- Shares
- +2,000,000
- Change %
- Price
- $0.000000*
- Shares after
- 2,000,000
- Date
- 16 Mar 2026
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,000,000
- Exercise price
- $0.4500
- Footnotes
- F1, F3, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
Represents Mr. Cohen's direct ownership of the Issuer.
Footnote F2
Shares held directly by The Tiger Cub Trust, which is beneficially owned by Jacob D. Cohen, its Trustee. Mr. Cohen disclaims beneficial ownership of the securities held by The Tiger Cub Trust except to the extent of his pecuniary interest therein.
Footnote F3
On March 16, 2026, the Issuer's Board of Directors, with the recommendation and approval of the Compensation Committee of the Board of Directors, approved an option repricing (the "Repricing") whereby the Reporting Person's options were repriced on March 16, 2026 (the "Effective Date") with a new exercise price of $0.45, which exceeded the closing price on Nasdaq as of the Effective Date. All of the other terms of the options remain unchanged. Such transactions were exempt pursuant to Rule 16b-6(d) and Rule 16b-3 of the Exchange Act, as applicable.
Footnote F4
A total of 1/3 of such options vested on each of September 1, 2023, 2024 and 2025.
Footnote F5
The options vest over 18 months with 500,000 of the options vesting upon grant on September 9, 2025, and 500,000 of the options vesting on the 6th, 12th, and 18th month anniversaries of the grant date, subject to Mr. Cohen's continued service with the Company on such vesting date; and vest in full upon any termination of Mr. Cohen by the Company without cause, or by Mr. Cohen for good reason, or upon a change of control of the Company.